125 related articles for article (PubMed ID: 10505418)
1. Antibiotic inhibitors of organellar protein synthesis in Plasmodium falciparum.
Clough B; Rangachari K; Strath M; Preiser PR; Wilson RJ
Protist; 1999 Aug; 150(2):189-95. PubMed ID: 10505418
[TBL] [Abstract][Full Text] [Related]
2. Interaction of apicoplast-encoded elongation factor (EF) EF-Tu with nuclear-encoded EF-Ts mediates translation in the Plasmodiumfalciparum plastid.
Biswas S; Lim EE; Gupta A; Saqib U; Mir SS; Siddiqi MI; Ralph SA; Habib S
Int J Parasitol; 2011 Mar; 41(3-4):417-27. PubMed ID: 21163263
[TBL] [Abstract][Full Text] [Related]
3. Elongation factor Tu3 (EF-Tu3) from the kirromycin producer Streptomyces ramocissimus Is resistant to three classes of EF-Tu-specific inhibitors.
Olsthoorn-Tieleman LN; Palstra RJ; van Wezel GP; Bibb MJ; Pleij CW
J Bacteriol; 2007 May; 189(9):3581-90. PubMed ID: 17337575
[TBL] [Abstract][Full Text] [Related]
4. Structure of an EF-Tu complex with a thiazolyl peptide antibiotic determined at 2.35 A resolution: atomic basis for GE2270A inhibition of EF-Tu.
Heffron SE; Jurnak F
Biochemistry; 2000 Jan; 39(1):37-45. PubMed ID: 10625477
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory mechanisms of antibiotics targeting elongation factor Tu.
Hogg T; Mesters JR; Hilgenfeld R
Curr Protein Pept Sci; 2002 Feb; 3(1):121-31. PubMed ID: 12370016
[TBL] [Abstract][Full Text] [Related]
6. Effects of the antibiotic pulvomycin on the elongation factor Tu-dependent reactions. Comparison with other antibiotics.
Anborgh PH; Okamura S; Parmeggiani A
Biochemistry; 2004 Dec; 43(49):15550-6. PubMed ID: 15581367
[TBL] [Abstract][Full Text] [Related]
7. Elongation factor Tu1 of the antibiotic GE2270A producer Planobispora rosea has an unexpected resistance profile against EF-Tu targeted antibiotics.
Möhrle VG; Tieleman LN; Kraal B
Biochem Biophys Res Commun; 1997 Jan; 230(2):320-6. PubMed ID: 9016775
[TBL] [Abstract][Full Text] [Related]
8. The apicoplast of Plasmodium falciparum is translationally active.
Chaubey S; Kumar A; Singh D; Habib S
Mol Microbiol; 2005 Apr; 56(1):81-9. PubMed ID: 15773980
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of bacterial protein synthesis by elongation-factor-Tu-binding antibiotics MDL 62,879 and efrotomycin.
Landini P; Bandera M; Goldstein BP; Ripamonti F; Soffientini A; Islam K; Denaro M
Biochem J; 1992 May; 283 ( Pt 3)(Pt 3):649-52. PubMed ID: 1590753
[TBL] [Abstract][Full Text] [Related]
10. Antibiotics MDL 62,879 and kirromycin bind to distinct and independent sites of elongation factor Tu (EF-Tu).
Landini P; Soffientini A; Monti F; Lociuro S; Marzorati E; Islam K
Biochemistry; 1996 Dec; 35(48):15288-94. PubMed ID: 8952479
[TBL] [Abstract][Full Text] [Related]
11. An elongation factor Tu (EF-Tu) resistant to the EF-Tu inhibitor GE2270 in the producing organism Planobispora rosea.
Sosio M; Amati G; Cappellano C; Sarubbi E; Monti F; Donadio S
Mol Microbiol; 1996 Oct; 22(1):43-51. PubMed ID: 8899707
[TBL] [Abstract][Full Text] [Related]
12. GE2270A-resistant mutations in elongation factor Tu allow productive aminoacyl-tRNA binding to EF-Tu.GTP.GE2270A complexes.
Zuurmond AM; Martien de Graaf J; Olsthoorn-Tieleman LN; van Duyl BY; Mörhle VG; Jurnak F; Mesters JR; Hilgenfeld R; Kraal B
J Mol Biol; 2000 Dec; 304(5):995-1005. PubMed ID: 11124042
[TBL] [Abstract][Full Text] [Related]
13. Mutant EF-Tu species reveal novel features of the enacyloxin IIa inhibition mechanism on the ribosome.
Zuurmond AM; Olsthoorn-Tieleman LN; Martien de Graaf J; Parmeggiani A; Kraal B
J Mol Biol; 1999 Dec; 294(3):627-37. PubMed ID: 10610785
[TBL] [Abstract][Full Text] [Related]
14. Enacyloxin IIa pinpoints a binding pocket of elongation factor Tu for development of novel antibiotics.
Parmeggiani A; Krab IM; Watanabe T; Nielsen RC; Dahlberg C; Nyborg J; Nissen P
J Biol Chem; 2006 Feb; 281(5):2893-900. PubMed ID: 16257965
[TBL] [Abstract][Full Text] [Related]
15. Amythiamicin D and related thiopeptides as inhibitors of the bacterial elongation factor EF-Tu: modification of the amino acid at carbon atom C2 of ring C dramatically influences activity.
Gross S; Nguyen F; Bierschenk M; Sohmen D; Menzel T; Antes I; Wilson DN; Bach T
ChemMedChem; 2013 Dec; 8(12):1954-62. PubMed ID: 24106106
[TBL] [Abstract][Full Text] [Related]
16. Functional role of the noncatalytic domains of elongation factor Tu in the interactions with ligands.
Cetin R; Anborgh PH; Cool RH; Parmeggiani A
Biochemistry; 1998 Jan; 37(2):486-95. PubMed ID: 9425069
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial activities of chemically modified thiazolyl peptide antibiotic MDL 62,879 (GE2270A).
Lociuro S; Tavecchia P; Marzorati E; Landini P; Goldstein BP; Denaro M; Ciabatti R
J Antibiot (Tokyo); 1997 Apr; 50(4):344-9. PubMed ID: 9186562
[TBL] [Abstract][Full Text] [Related]
18. Mutations to kirromycin resistance occur in the interface of domains I and III of EF-Tu.GTP.
Abdulkarim F; Liljas L; Hughes D
FEBS Lett; 1994 Sep; 352(2):118-22. PubMed ID: 7925958
[TBL] [Abstract][Full Text] [Related]
19. EF-Tu from the enacyloxin producing Frateuria W-315 strain: Structure/activity relationship and antibiotic resistance.
Créchet JB; Malosse C; Hountondji C
Biochimie; 2016 Aug; 127():59-69. PubMed ID: 27126073
[TBL] [Abstract][Full Text] [Related]
20. Enacyloxin IIa, an inhibitor of protein biosynthesis that acts on elongation factor Tu and the ribosome.
Cetin R; Krab IM; Anborgh PH; Cool RH; Watanabe T; Sugiyama T; Izaki K; Parmeggiani A
EMBO J; 1996 May; 15(10):2604-11. PubMed ID: 8665868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
